UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy

Annals of oncology, 2012-05, Vol.23 (5), p.1241-1249

2012

Volltextzugriff (PDF)

Combination Versus Sequential Doxorubicin and Docetaxel as Primary Chemotherapy for Breast Cancer: A Randomized Pilot Trial of the Hoosier Oncology Group

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3033-3037

1999

Volltextzugriff (PDF)

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923

2011

Volltextzugriff (PDF)

Evaluation of indibulin, a novel tubulin targeting-agent, in combination with capecitabine, with mathematically optimized dose scheduling

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.2538-2538

2009

Volltextzugriff (PDF)

A randomized, multicenter phase III trial comparing doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for high-risk breast cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.517-517

2007

Volltextzugriff (PDF)

Phase II multicenter, two-stage study of E7389 in patients with hormone refractory prostate cancer with advanced and/or metastatic disease stratified by prior chemotherapy

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.15513-15513

2007

Volltextzugriff (PDF)

Pharmacokinetics of ametantrone acetate (NSC-287513)

Cancer chemotherapy and pharmacology, 1987-01, Vol.19 (2), p.133-137

1987

Volltextzugriff (PDF)

Updated report of a phase III study of induction therapy with gemcitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7032-7032

2006

Volltextzugriff (PDF)

A phase III study of induction therapy with gemcitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7142-7142

2005

Volltextzugriff (PDF)

Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age ≥75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4646-4646

2005

Volltextzugriff (PDF)

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy

Annals of oncology, 2012-05, Vol.23 (5), p.1241

2012

Volltextzugriff (PDF)

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.573-573

2004

Volltextzugriff (PDF)

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.573-573

2004

Volltextzugriff (PDF)

Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early stage non-small cell lung cancer (NSCLC): Initial results of the GINEST • project

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.7215-7215

2005

Volltextzugriff (PDF)

The impact of neoadjuvant chemotherapy and surgery on quality of life (QL) in patients with early stage NSCLC: A prospective analysis of the GINEST project

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8092-8092

2005

Volltextzugriff (PDF)

Phase I investigation of ametantrone

Cancer treatment reports, 1983-11, Vol.67 (11), p.987

1983

Volltextzugriff (PDF)

Removal of a knotted flow-directed catheter by a nonsurgical method

Annals of internal medicine, 1980-05, Vol.92 (5), p.639

1980

Volltextzugriff (PDF)

Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group

Cancer treatment reports, 1982-12, Vol.66 (12), p.2099

1982

Volltextzugriff (PDF)

A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer

Breast cancer research and treatment, 2003, Vol.77 (2), p.115-123

2003

Volltextzugriff (PDF)

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4877-4883

2010

Volltextzugriff (PDF)

Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital

World journal of surgical oncology, 2023-06, Vol.21 (1), p.176-176, Article 176

2023

Volltextzugriff (PDF)

Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study

European journal of surgical oncology, 2024-09, Vol.50 (9), p.108478, Article 108478

2024

Volltextzugriff (PDF)

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Nature (London), 2021-02, Vol.590 (7845), p.290-299

2021

Volltextzugriff (PDF)

Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism

Clinical genetics, 2009-11, Vol.76 (5), p.471-476

2009

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(177)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy

Combination Versus Sequential Doxorubicin and Docetaxel as Primary Chemotherapy for Breast Cancer: A Randomized Pilot Trial of the Hoosier Oncology Group

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Evaluation of indibulin, a novel tubulin targeting-agent, in combination with capecitabine, with mathematically optimized dose scheduling

A randomized, multicenter phase III trial comparing doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for high-risk breast cancer

Phase II multicenter, two-stage study of E7389 in patients with hormone refractory prostate cancer with advanced and/or metastatic disease stratified by prior chemotherapy

Pharmacokinetics of ametantrone acetate (NSC-287513)

Updated report of a phase III study of induction therapy with gemcitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer (NSCLC)

A phase III study of induction therapy with gemcitabine + carboplatin (GC) followed by either delayed vs. immediate second-line therapy with docetaxel (D) in advanced non-small cell lung cancer (NSCLC)

Phase II study of low dose (weekly) docetaxel and estramustine in elderly males (age ≥75 years) with hormone-refractory prostate cancer or patients age 18 to 74 years with an ECOG performance status of 2 or 3

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Randomized phase III study of trastuzumab, paclitaxel, and carboplatin versus trastuzumab and paclitaxel in women with HER-2 overexpressing metastatic breast cancer: An update including survival

Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early stage non-small cell lung cancer (NSCLC): Initial results of the GINEST • project

The impact of neoadjuvant chemotherapy and surgery on quality of life (QL) in patients with early stage NSCLC: A prospective analysis of the GINEST project

Phase I investigation of ametantrone

Removal of a knotted flow-directed catheter by a nonsurgical method

Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group

A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital

Limb development genes underlie variation in human fingerprint patterns

Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery – A retrospective cohort study

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism

Suchergebnisse filtern